Guggenheim Capital’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-18,715
| Closed | -$263K | – | 2034 |
|
|
2022
Q2 | $263K | Sell |
18,715
-2,007
| -10% | -$28.2K | ﹤0.01% | 1837 |
|
|
2022
Q1 | $297K | Sell |
20,722
-85
| -0.4% | -$1.22K | ﹤0.01% | 1887 |
|
|
2021
Q4 | $284K | Sell |
20,807
-2,224
| -10% | -$30.4K | ﹤0.01% | 1894 |
|
|
2021
Q3 | $377K | Buy |
23,031
+2,131
| +10% | +$34.9K | ﹤0.01% | 1850 |
|
|
2021
Q2 | $352K | Buy |
+20,900
| New | +$352K | ﹤0.01% | 1961 |
|
|
2020
Q4 | – | Sell |
-10,534
| Closed | -$188K | – | 2112 |
|
|
2020
Q3 | $188K | Sell |
10,534
-1,229
| -10% | -$21.9K | ﹤0.01% | 1801 |
|
|
2020
Q2 | $211K | Sell |
11,763
-3,846
| -25% | -$69K | ﹤0.01% | 1726 |
|
|
2020
Q1 | $237K | Buy |
15,609
+2,127
| +16% | +$32.3K | ﹤0.01% | 1611 |
|
|
2019
Q4 | $266K | Buy |
13,482
+1,496
| +12% | +$29.5K | ﹤0.01% | 1886 |
|
|
2019
Q3 | $206K | Buy |
+11,986
| New | +$206K | ﹤0.01% | 1998 |
|